N.I.H. Workers Denounce Trump’s ‘Harmful’ Health Policies
In a scathing public letter, employees of the National Institutes of Health accused the administration of undermining the agency’s work and endangering people’s health.
Related Articles
How immigration raids at Ambiance Apparel and Home Depot led to the Los Angeles protests
Trump’s escalation of immigration arrests by shifting into workplaces ignited clashes between protesters and officers in the immigrant-heavy city.
Sign the Bethesda Declaration
Not all public health declarations need to involve “let ‘er rip” mass infection strategies
RFK Jr. Purging the CDC Advisory Committee Will Put Lives at Risk
“The stakes are high, but a better path is possible,” writes Trump’s first Surgeon General Dr. Jerome Adams.
Medical experts slam Kennedy’s dismissal of CDC vaccine advisers
Health Secretary Robert F. Kennedy Jr.’s decision to remove every member of the Centers for Disease Control and Prevention’s vaccine advisory committee has sparked major…
RFK Jr.’s attack on vaccine experts endangers every American
“Our nation’s top health official cannot be trusted to protect America’s children and their families,” writes Richard Besser, pediatrician and president of the Robert Wood…
FDA approves Merck RSV monoclonal antibody shot for infants
The approval is the second for an RSV monoclonal antibody preventive for infants.
HHS budget proposal eliminates CDC’s chronic disease, global health centers in favor of new “MAHA” agency
The proposed budget for the Department of Health and Human Services slashes CDC and NIH funding in favor of the new Administration for a Healthy…
Arizona confirms first measles cases as totals rise in other states
Also, Colorado reported 2 more cases, including another linked to airport exposure.
Antiviral drugs oseltamivir, onradivir may lead to better flu outcomes
University of Minnesota http://twin-cities.umn.edu/ 612-625-5000 A pair of new studies detail the benefits of antiviral drugs for flu patients, one linking oseltamivir with lower odds…
FDA to review new oral gonorrhea antibiotic
University of Minnesota http://twin-cities.umn.edu/ 612-625-5000 Drugmaker Innoviva Specialty Therapeutics announced today that the US Food and Drug Administration (FDA) has accepted its new drug application…